Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Orexigen Therapeutics, Inc. | 350,000 | reported | 02 Feb 2016 | tx 30+3,218,810−1,184,000 |
| ARENA PHARMACEUTICALS INC | 70,000 | reported | 01 Mar 2020 | tx 15+1,606,400−46,609 |
| Conatus Pharmaceuticals Inc | 20,000 | reported | 27 Jun 2019 | tx 6+125,000 |
| Metacrine, Inc. | 0 | reported | 23 Mar 2023 | tx 10+2,056,969−2,109,775 |
| Regulus Therapeutics Inc. | 0 | reported | 25 Jun 2025 | tx 15+1,977,500−2,045,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 115,555 | — | |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 675,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 528,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 350,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 225,000 | — | deriv |
| 25 Jun 2025 | OTHER | Regulus Therapeutics Inc. | 120,000 | — | deriv |
| 03 Jun 2025 | PURCHASE | Regulus Therapeutics Inc. | 12,000 | 7.99 USD | first after silence |
| 30 Jan 2025 | GRANT_AWARD | Regulus Therapeutics Inc. | 675,000 | 0.00 USD | deriv |
| 13 Jan 2025 | SALE | Regulus Therapeutics Inc. | 31,445 | 1.26 USD | |
| 09 Jan 2025 | GRANT_AWARD | Regulus Therapeutics Inc. | 30,000 | 1.30 USD | |
| 09 Jan 2025 | GRANT_AWARD | Regulus Therapeutics Inc. | 37,500 | 1.36 USD | |
| 20 May 2024 | GRANT_AWARD | Regulus Therapeutics Inc. | 528,000 | 0.00 USD | deriv |
| 12 Jan 2024 | GRANT_AWARD | Regulus Therapeutics Inc. | 120,000 | 0.00 USD | deriv |
| 10 Aug 2023 | GRANT_AWARD | Regulus Therapeutics Inc. | 225,000 | 0.00 USD | deriv |
| 12 Jun 2023 | GRANT_AWARD | Regulus Therapeutics Inc. | 350,000 | 0.00 USD | deriv |
| 23 Mar 2023 | GRANT_AWARD | Metacrine, Inc. | 842,211 | 0.47 USD | |
| 23 Mar 2023 | OTHER | Metacrine, Inc. | 842,211 | 0.00 USD | deriv |
| 26 Jan 2023 | SALE | Metacrine, Inc. | 380,605 | 0.41 USD | |
| 19 Apr 2022 | SALE | Metacrine, Inc. | 43,575 | 0.50 USD | |
| 19 Apr 2022 | SALE | Metacrine, Inc. | 1,173 | 0.51 USD | |
| 14 Apr 2022 | GRANT_AWARD | Metacrine, Inc. | 104,500 | 0.00 USD | |
| 27 Feb 2022 | GRANT_AWARD | Metacrine, Inc. | 842,211 | 0.00 USD | |
| 27 Feb 2022 | GRANT_AWARD | Metacrine, Inc. | 842,211 | 0.00 USD | deriv |
| 20 May 2021 | PURCHASE | Metacrine, Inc. | 20,547 | 3.64 USD | |
| 10 Feb 2021 | GRANT_AWARD | Metacrine, Inc. | 247,500 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 03 Jun 2025.